This one drug type is hitting not just diabetes, not just heart disease, not just weight, but all of them it targets overall cardiometabolic risk
The medication has demonstrated effectiveness in reducing HbA1c levels and can support weight management, though it is not licensed for weight loss (unlike Wegovy, which contains the same active ingredient at a higher dose)
Fat-burning/metabolic support protocols : 12 times per week for 46 weeks Ongoing energy and wellness maintenance : Weekly or biweekly Mild B12 deficiency : Weekly for 46 weeks, then monthly As with any injection regimen, consistency is key
Discontinuing the medication often leads to weight regain without continued habits and support
This balance triggers your GIP and GLP-1 receptors optimally, maximizing appetite suppression while providing sustained energy
The American Society of Anesthesiologists recommends treating patients who are taking GLP-1 receptor agonists as if they have a full stomach with appropriate airway protection and rapid induction of anaesthesia
